Torley Helen

CIK 00015281854 companiesSAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001528185

Recent Transactions

50 trades

Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-09-11$18.41/sh+20,000→ 787,780 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-09-11$107.55/sh−4,508→ 767,780 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-09-11$107.15/sh−15,492→ 772,288 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Option to Purchase Common Stock
2026-09-11$18.41/sh−20,000→ 81,552 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Option to Purchase Common Stock
2026-09-10$18.41/sh−20,000→ 101,552 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-09-10$18.41/sh+20,000→ 787,780 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-09-10$107.58/sh−5,412→ 767,780 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-09-10$107.01/sh−14,588→ 773,192 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Option to Purchase Common Stock
2026-09-09$18.41/sh−20,000→ 121,552 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-09-09$107.22/sh−13,304→ 774,476 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-09-09$18.41/sh+20,000→ 787,780 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-09-09$108.67/sh−100→ 767,780 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-09-09$107.82/sh−6,596→ 767,880 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-08-19$106.36/sh−7,200→ 780,580 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-08-19$107.22/sh−9,600→ 770,980 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Option to Purchase Common Stock
2026-08-19$18.41/sh−20,000→ 141,552 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-08-19$107.77/sh−3,200→ 767,780 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-08-19$18.41/sh+20,000→ 787,780 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-08-18$18.41/sh+20,000→ 787,780 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-08-18$104.11/sh−4,897→ 777,180 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-08-18$103.08/sh−5,703→ 782,077 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Option to Purchase Common Stock
2026-08-18$18.41/sh−20,000→ 161,552 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-08-18$104.87/sh−9,400→ 767,780 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-08-17$100.46/sh−500→ 786,380 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-08-17$101.77/sh−2,100→ 784,280 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-08-17$98.96/sh−900→ 786,880 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-08-17$102.55/sh−9,000→ 775,280 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-08-17$103.48/sh−7,500→ 767,780 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Option to Purchase Common Stock
2026-08-17$18.41/sh−20,000→ 181,552 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-08-17$18.41/sh+20,000→ 787,780 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Option to Purchase Common Stock
2026-07-08$12.07/sh−1,923→ 0 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-07-08$80.19/sh−1,035→ 767,780 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-07-08$79.28/sh−888→ 768,815 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-07-08$12.07/sh+1,923→ 769,703 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-06-03$66.37/sh−400→ 777,380 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-06-03$69.69/sh−6,100→ 767,780 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-06-03$67.67/sh−1,500→ 775,880 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Option to Purchase Common Stock
2026-06-03$12.07/sh−10,000→ 1,923 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-06-03$12.07/sh+10,000→ 777,780 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-06-03$68.74/sh−2,000→ 773,880 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-06-02$12.07/sh+20,000→ 787,780 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Option to Purchase Common Stock
2026-06-02$12.07/sh−20,000→ 11,923 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-06-02$66.75/sh−3,400→ 767,780 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-06-02$66.31/sh−16,600→ 771,180 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-06-01$66.39/sh−1,610→ 786,170 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-06-01$67.41/sh−12,989→ 773,181 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-06-01$68.35/sh−5,401→ 767,780 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-06-01$12.07/sh+20,000→ 787,780 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Option to Purchase Common Stock
2026-06-01$12.07/sh−20,000→ 31,923 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-05-13$69.79/sh−3,950→ 768,380 total

Companies

Recent Filings

Address

C/O HALOZYME THERAPEUTICS, INC. 12390 EL CAMINO REAL

SAN DIEGO, CA, 92130

View on SEC.gov